CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma

NCT02336386 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Extramedullary Plasmacytoma

Interventions

DRUG: CDD
DRUG: CDD Plus Bortezomib

Sponsor

Beijing Chao Yang Hospital

Collaborators

[object Object]